Infectious Diseases (except HIV/AIDS)

  1. A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part

    1. Hiroshi Mukae
    2. Hiroshi Yotsuyanagi
    3. Norio Ohmagari
    4. Yohei Doi
    5. Takumi Imamura
    6. Takuhiro Sonoyama
    7. Takahiro Fukuhara
    8. Genki Ichihashi
    9. Takao Sanaki
    10. Keiko Baba
    11. Yosuke Takeda
    12. Yuko Tsuge
    13. Takeki Uehara

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination

    1. Grace Kenny
    2. Riya Negi
    3. Sophie O'Reilly
    4. Alejandro Garcia-Leon
    5. Dana Alalwan
    6. Colette Marie Gaillard
    7. Gurvin Saini
    8. Rosana Inzitari
    9. Eoin R. Feeney
    10. Obada Yousif
    11. Aoife G Cotter
    12. Eoghan de Barra
    13. Corinna Sadlier
    14. Fiona Crispie
    15. Peter Doran
    16. Virginie Gautier
    17. Patrick W.G. Mallon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial

    1. Muhammad Raza Shah
    2. Samreen Fatima
    3. Sehrosh Naz Khan
    4. Shafi Ullah
    5. Gulshan Himani
    6. Kelvin Wan
    7. Timothy Lin
    8. Johnson Y. N. Lau
    9. Qingquan Liu
    10. Dennis S. C. Lam

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Antibody Response to SARS-CoV-2 among COVID-19 Confirmed Cases and Correlates with Neutralizing Assay in a Subgroup of Patients in Delhi National Capital Region, India

    1. Puneet Misra
    2. Shashi Kant
    3. Randeep Guleria
    4. Sanjay K. Rai
    5. Abhishek Jaiswal
    6. Suprakash Mandal
    7. Guruprasad R. Medigeshi
    8. Mohammad Ahmad
    9. Anisur Rahman
    10. Meenu Sangral
    11. Kapil Yadav
    12. Mohan Bairwa
    13. Partha Haldar
    14. Parveen Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. A hybrid approach to predict COVID-19 cases using neural networks and inverse problem

    1. Subhendu Paul
    2. Emmanuel Lorin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. BIRC6 modifies risk of invasive bacterial infection in Kenyan children

    1. James J Gilchrist
    2. Silvia N Kariuki
    3. James A Watson
    4. Gavin Band
    5. Sophie Uyoga
    6. Carolyne M Ndila
    7. Neema Mturi
    8. Salim Mwarumba
    9. Shebe Mohammed
    10. Moses Mosobo
    11. Kaur Alasoo
    12. Kirk A Rockett
    13. Alexander J Mentzer
    14. Dominic P Kwiatkowski
    15. Adrian VS Hill
    16. Kathryn Maitland
    17. J Anthony G Scott
    18. Thomas N Williams

    • Curated by eLife

      Evaluation Summary:

      The paper presents evidence that a genetic variant in the BIRC6 gene increases the risk of invasive bacterial infection. This paper will be of interest to researchers working in areas relating to invasive bacterial infections, malaria, sepsis, and immunogenetics. While this paper presents a hypothesis for the mechanism through which the risk variant acts, larger samples carrying the variant that increases risk, only present in African populations, are needed to further investigate potential mechanisms.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 and Reviewer #3 agreed to share their name with the authors.)

    Reviewed by eLife

    5 evaluationsAppears in 1 listLatest version Latest activity

  7. Quantifying the information in noisy epidemic curves

    1. Kris V. Parag
    2. Christl A. Donnelly
    3. Alexander E. Zarebski

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. A Phase1 Results of a Non-Stabilized Spike-Encoding mRNA Vaccine in Adults

    1. Sivaporn Gatechompol
    2. Wonngarm Kittanamongkolchai
    3. Chutitorn Ketloy
    4. Eakachai Prompetchara
    5. Arunee Thitithanyanont
    6. Anan Jongkaewwattana
    7. Supranee Buranapraditkun
    8. Mohamad-Gabriel Alameh
    9. Sasiwimol Ubolyam
    10. Jiratchaya Sophonphan
    11. Tanakorn Apornpong
    12. Stephen Kerr
    13. Adeeba Kamarulzaman
    14. Sarawut Siwamogsatham
    15. Eugène Kroon
    16. Thanyawee Puthanakit
    17. Kanitha Patarakul
    18. Tanapat Palaga
    19. Wassana Wijagkanalan
    20. Drew Weissman
    21. Kiat Ruxrungtham
    22. ChulaVAC-001 study team

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A Deterministic Agent-based Model with Antibody Dynamics Information in COVID-19 Epidemic Simulation

    1. Zhaobin Xu
    2. Hongmei Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients

    1. Eden Avnat
    2. Guy Shapira
    3. David Gurwitz
    4. Noam Shomron

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 160 of 716 Next